Innovative Therapeutic Strategies for the Treatment of Repeated Implantation Failure - An Update

    February 2023 in “ Acta Scientific Women s Health ”
    Kulvinder Kochar Kaur, Gautam Allahbadia, Mandeep Singh
    TLDR New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.
    The document discussed innovative therapeutic strategies for treating Recurrent Implantation Failure (RIF), focusing on three promising approaches: the use of peripheral blood mononuclear cells (PBMC), subcutaneous administration of Granulocyte Colony-Stimulating Factor (G-CSF), and platelet-rich plasma (PRP). These strategies were highlighted as attractive options for aiding RIF patients. Additionally, the document reviewed other immune therapies used in the past, such as intrauterine insemination of hCG, intravenous immunoglobulins (IVIG), intravenous intralipid, and heparin, detailing their mechanisms of action.
    Discuss this study in the Community →